Expertise in
8
conditions

Dar Dowlatshahi

Room C2182, 1053 Carling Avenue, K1Y 4E9, 
Ottawa, ON, CA 
Expertise in
8
conditions
Room C2182, 1053 Carling Avenue, K1Y 4E9, 
Ottawa, ON, CA 

Overview

Dar Dowlatshahi practices practicing medicine in Ottawa, Canada.

Mr. Dowlatshahi is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Carotid Artery Disease, Thrombectomy, and Carotid Artery Surgery.

He is actively involved in clinical research, co-authoring 334 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Room C2182, 1053 Carling Avenue, K1Y 4E9, Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Completed
Publish Date: September 01, 2026
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Enrollment Status: Terminated
Publish Date: November 06, 2024
Intervention Type: Drug
Study Drug: Labetalol+Hydralazine+Enalapril
Study Phase: Phase 2
Recovernow: A Multicentre Phase II Randomized Controlled Trial Of Early Mobile Tablet-Based Speech Therapy For Acute Stroke Patients With Aphasia
Recovernow: A Multicentre Phase II Randomized Controlled Trial Of Early Mobile Tablet-Based Speech Therapy For Acute Stroke Patients With Aphasia
Enrollment Status: Terminated
Publish Date: April 19, 2022
Intervention Type: Other
Study Phase: Not Applicable
Canadian Pradaxa Acute Stroke Safety Study
Canadian Pradaxa Acute Stroke Safety Study
Enrollment Status: Completed
Publish Date: June 19, 2020
Intervention Type: Drug
View 3 Less Clinical Trials

334 Total Publications

Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.
Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage: A Placebo-Controlled Trial.
Journal: Stroke
Published: August 06, 2026

Frequently Asked Questions about Dar Dowlatshahi

Is Dar Dowlatshahi a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Dar Dowlatshahi is classified as an Elite expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dar Dowlatshahi participate in research or clinical trials?

Yes. Dar Dowlatshahi has published 334 articles and abstracts on conditions like Stroke. You can view a list of Dar Dowlatshahi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dowlatshahi's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile